Cenovus Energy Inc vs Tilray Brands Inc — how do they compare? Cenovus Energy Inc trades at $29.93 (market cap $54.43B), while Tilray Brands Inc trades at $4.77 (market cap $601.34M). The key difference: Cenovus Energy Inc is far larger — about 90.5× Tilray Brands Inc's market cap, and Cenovus Energy Inc pays a 2.11% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| CVE | TLRY | |
|---|---|---|
Market Cap | $54.43B | $601.34M |
Sector | Energy | Health |
52-Week High | $31.80 | $21.00 |
52-Week Low | $14.83 | $3.88 |
Enterprise Value | $60.50B | $768.47M |
Dividend Yield | 2.11% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.
Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.
Trailing returns across standard periods
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →